Caption Management, LLC Spring Works Therapeutics, Inc. Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $146,000 - $210,000	4,000 New	4,000 $196,000
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $425,713 - $1.39 Million	-23,187 Reduced 92.08%	1,993 $49,000
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $1.23 Million - $1.65 Million	25,180 New	25,180 $1.42 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.27B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.